WA HB 2613
died on adjournmentEstablishing safety and regulatory requirements for compounded medications.
Washington · 2026 Regular Session · lower
Quick answers
Did WA HB 2613 pass?
No. WA HB 2613 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-01-30): Public hearing in the House Committee on Health Care & Wellness at 8:00 AM.
What is WA HB 2613 about?
WA HB 2613 is a bill in the 2026 Regular Session titled “Establishing safety and regulatory requirements for compounded medications.”.
Who sponsors WA HB 2613?
Thai is the primary sponsor of WA HB 2613, joined by 5 cosponsors.
- Introduced
- —
- Latest action
- 2026-01-30 — Public hearing in the House Committee on Health Care & Wellness at 8:00 AM.
- Bill type
- bill
- Last updated
- —
Sponsors
- Thaiprimary
- Hillcosponsor
- Ormsbycosponsor
- Santoscosponsor
- Duerrcosponsor
- Parshleycosponsor
Committees
Not provided by source.
Action timeline
2026-01-21
First reading, referred to Health Care & Wellness.
reading-1,referral-committee
2026-01-30
Public hearing in the House Committee on Health Care & Wellness at 8:00 AM.
Versions
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:37:10.718715Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=WA&identifier=HB 2613. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.